234(top 1%)
PR articles
10.8K(top 1%)
PR citations
55(top 1%)
PR h-index
60(top 1%)
h-index
249
documents
13.4K
doc citations
2.9K
citing journals
100
times ranked

Publications

236 peer-reviewed articles • 11,801 peer-reviewed citations • Sorted by year • Download PDF (PDF by citations)
Sort: Year | Citations
#ArticleIFCitationsLinks
1How context, mood, and emotional memory interact in depression: A study in everyday life.
Emotion, 2023, 23, 41-51
1.914Citations (PDF)
2Substance use disorder and alcohol consumption patterns among Dutch physicians: a nationwide register-based study2.57Citations (PDF)
3What we learn about bipolar disorder from large‐scale neuroimaging: Findings and future directions from the ENIGMA Bipolar Disorder Working Group
Human Brain Mapping, 2022, 43, 56-82
3.5147Citations (PDF)
4Effects of substance misuse on inhibitory control in patients with attention‐deficit/hyperactivity disorder
Addiction Biology, 2022, 27,
2.61Citations (PDF)
5Effects of family history of substance use disorder on reward processing in adolescents with and without attention‐deficit/hyperactivity disorder
Addiction Biology, 2022, 27,
2.64Citations (PDF)
6rTMS Reduces Craving and Alcohol Use in Patients with Alcohol Use Disorder: Results of a Randomized, Sham-Controlled Clinical Trial2.529Citations (PDF)
7Biomarkers as predictors of treatment response to tricyclic antidepressants in major depressive disorder: A systematic review2.98Citations (PDF)
8Depressive Symptoms Account for Loss of Positive Attention Bias in ADHD Patients: An Eye-Tracking Study
Journal of Attention Disorders, 2022, 26, 1325-1334
2.73Citations (PDF)
9Amygdala sensitivity for negative information as a neural marker for negative memory bias across psychiatric diagnoses1.911Citations (PDF)
10Suicidal ideation in remitted major depressive disorder predicts recurrence2.925Citations (PDF)
11Negative cognitive schema modification as mediator of symptom improvement after electroconvulsive therapy in major depressive disorder
Journal of Affective Disorders, 2022, 310, 156-161
4.59Citations (PDF)
12Neural correlates of repetitive negative thinking: Dimensional evidence across the psychopathological continuum2.412Citations (PDF)
13Negative Learning Bias in Depression Revisited: Enhanced Neural Response to Surprising Reward Across Psychiatric Disorders1.25Citations (PDF)
14Success Rates of Monitoring for Healthcare Professionals with a Substance Use Disorder: A Meta-Analysis2.516Citations (PDF)
15Is a Negative Attentional Bias in Individuals with Autism Spectrum Disorder Explained by Comorbid Depression? An Eye-Tracking Study2.16Citations (PDF)
16The Effect of Alexithymia on Attentional Bias Toward Emotional Stimuli in Depression: An Eye-Tracking Study2.43Citations (PDF)
17Maladaptive emotion regulation strategies in a vulnerable population predict increased anxiety during the Covid-19 pandemic: A pseudo-prospective study1.235Citations (PDF)
18The Role of Perseverative Cognition for Both Mental and Somatic Disorders in a Naturalistic Psychiatric Patient Sample
Psychosomatic Medicine, 2021, 83, 1058-1066
2.12Citations (PDF)
19Beneficial Effects of Opioid Rotation to Buprenorphine/Naloxone on Opioid Misuse, Craving, Mental Health, and Pain Control in Chronic Non-Cancer Pain Patients with Opioid Use Disorder2.59Citations (PDF)
20Tricyclic antidepressants for major depressive disorder: a comprehensive evaluation of current practice in the Netherlands
BMC Psychiatry, 2021, 21,
3.122Citations (PDF)
21Effects of substance misuse and current family history of substance use disorder on brain structure in adolescents and young adults with attention-deficit/hyperactivity disorder
Drug and Alcohol Dependence, 2021, 228, 109032
2.96Citations (PDF)
22Metabolic features of recurrent major depressive disorder in remission, and the risk of future recurrence5.236Citations (PDF)
23Systematic review of cognitive biases in autism spectrum disorders: A neuropsychological framework towards an understanding of the high prevalence of co-occurring depression1.815Citations (PDF)
24The relationship between childhood adversity and adult personality revealed by network analysis
Child Abuse and Neglect, 2020, 99, 104254
2.831Citations (PDF)
25Modification of the association between paroxetine serum concentration and SERT-occupancy by ABCB1 (P-glycoprotein) polymorphisms in major depressive disorder
Psychiatric Genetics, 2020, 30, 19-29
1.314Citations (PDF)
26Negative memory bias as a transdiagnostic cognitive marker for depression symptom severity
Journal of Affective Disorders, 2020, 274, 1165-1172
4.555Citations (PDF)
27A randomized controlled trial of a standard 4-week protocol of repetitive transcranial magnetic stimulation in severe treatment resistant depression
Journal of Affective Disorders, 2020, 274, 444-449
4.521Citations (PDF)
28Contribution of Alcohol and Nicotine Dependence to the Prevalence of Depressed Mood in Different Ethnic Groups in The Netherlands: The HELIUS Study
Journal of Dual Diagnosis, 2020, 16, 271-284
1.55Citations (PDF)
29Absence of default mode downregulation in response to a mild psychological stressor marks stress-vulnerability across diverse psychiatric disorders
NeuroImage: Clinical, 2020, 25, 102176
3.328Citations (PDF)
30Physicians' norms and attitudes towards substance use in colleague physicians: A cross-sectional survey in the Netherlands
PLoS ONE, 2020, 15, e0231084
2.315Citations (PDF)
31Effects of substance misuse on reward-processing in patients with attention-deficit/hyperactivity disorder
Neuropsychopharmacology, 2020, 46, 622-631
5.410Citations (PDF)
32Impaired reward-related learning signals in remitted unmedicated patients with recurrent depression
Brain, 2019, 142, 2510-2522
8.464Citations (PDF)
33Iatrogenic opioid use disorder, chronic pain and psychiatric comorbidity: A systematic review2.653Citations (PDF)
34Attentional control, rumination and recurrence of depression
Journal of Affective Disorders, 2019, 256, 364-372
4.536Citations (PDF)
35Altered ability to access a clinically relevant control network in patients remitted from major depressive disorder
Human Brain Mapping, 2019, 40, 2771-2786
3.5113Citations (PDF)
36Emotional Biases and Recurrence in Major Depressive Disorder. Results of 2.5 Years Follow-Up of Drug-Free Cohort Vulnerable for Recurrence2.455Citations (PDF)
37Effectiveness of a self-management training for patients with chronic and treatment resistant anxiety or depressive disorders on quality of life, symptoms, and empowerment: results of a randomized controlled trial
BMC Psychiatry, 2019, 19,
3.120Citations (PDF)
38Associations between impulsivity, risk behavior and HIV, HBV, HCV and syphilis seroprevalence among female prisoners in Indonesia: A cross-sectional study
PLoS ONE, 2019, 14, e0207970
2.319Citations (PDF)
39Use of the Fagerström test to assess differences in the degree of nicotine dependence in smokers from five ethnic groups: The HELIUS study
Drug and Alcohol Dependence, 2019, 194, 197-204
2.912Citations (PDF)
40Cortisol, dehydroepiandrosterone sulfate, fatty acids, and their relation in recurrent depression
Psychoneuroendocrinology, 2019, 100, 203-212
2.720Citations (PDF)
41A Pilot Study of Smartphone-Based Memory Bias Modification and Its Effect on Memory Bias and Depressive symptoms in an Unselected Population1.516Citations (PDF)
42The measurement of cognitive reactivity to sad mood in patients remitted from major depressive disorder5.215Citations (PDF)
43Effectiveness of preventive cognitive therapy while tapering antidepressants versus maintenance antidepressant treatment versus their combination in prevention of depressive relapse or recurrence (DRD study): a three-group, multicentre, randomised controlled trial
Lancet Psychiatry,the, 2018, 5, 401-410
17.3117Citations (PDF)
44Decreased Cognitive Functioning After Electroconvulsive Therapy Is Related to Increased Hippocampal Volume
Journal of ECT, 2018, 34, 117-123
0.857Citations (PDF)
45The use and helpfulness of self-management strategies for depression: The experiences of patients
PLoS ONE, 2018, 13, e0206262
2.330Citations (PDF)
46Symptomatic and functional recovery in depression in later life2.618Citations (PDF)
47Dried Blood Spot sampling in psychiatry: Perspectives for improving therapeutic drug monitoring1.033Citations (PDF)
48Biological profiling of prospective antidepressant response in major depressive disorder: Associations with (neuro)inflammation, fatty acid metabolism, and amygdala-reactivity
Psychoneuroendocrinology, 2017, 79, 84-92
2.736Citations (PDF)
49Dietary pattern derived by reduced rank regression and depressive symptoms in a multi-ethnic population: the HELIUS study2.515Citations (PDF)
50Associations Between Daily Affective Instability and Connectomics in Functional Subnetworks in Remitted Patients with Recurrent Major Depressive Disorder
Neuropsychopharmacology, 2017, 42, 2583-2592
5.441Citations (PDF)
51Plasma lipoproteins in posttraumatic stress disorder patients compared to healthy controls and their associations with the HPA- and HPT-axis
Psychoneuroendocrinology, 2017, 86, 209-217
2.718Citations (PDF)
52How the brain connects in response to acute stress: A review at the human brain systems level6.8238Citations (PDF)
53Perceived Ethnic Discrimination and the Metabolic Syndrome in Ethnic Minority Groups: The Healthy Life in an Urban Setting Study
Psychosomatic Medicine, 2017, 79, 101-111
2.129Citations (PDF)
54Childhood trauma and negative memory bias as shared risk factors for psychopathology and comorbidity in a naturalistic psychiatric patient sample2.445Citations (PDF)
55Aberrant default-mode network-hippocampus connectivity after sad memory-recall in remitted-depression2.760Citations (PDF)
56ADHD symptoms in healthy adults are associated with stressful life events and negative memory bias2.328Citations (PDF)
57The role of mastery in the relationship between perceived ethnic discrimination and depression: The HELIUS study.1.912Citations (PDF)
58Helpful Factors in the Treatment of Depression from the Patient’s, Carer’s and Professional’s Perspective: A Concept Map Study
PLoS ONE, 2016, 11, e0167719
2.37Citations (PDF)
59Vulnerability for new episodes in recurrent major depressive disorder: protocol for the longitudinal DELTA-neuroimaging cohort study
BMJ Open, 2016, 6, e009510
1.931Citations (PDF)
60Deep Brain Stimulation of the Ventral Anterior Limb of the Internal Capsule for Treatment-Resistant Depression
JAMA Psychiatry, 2016, 73, 456
12.4332Citations (PDF)
61Default mode network coherence in treatment-resistant major depressive disorder during electroconvulsive therapy
Journal of Affective Disorders, 2016, 205, 130-137
4.570Citations (PDF)
62The Dutch Measure for quantification of Treatment Resistance in Depression (DM-TRD): an extension of the Maudsley Staging Method
Journal of Affective Disorders, 2016, 205, 365-371
4.567Citations (PDF)
63Fatty acid concentrations in patients with posttraumatic stress disorder compared to healthy controls
Journal of Affective Disorders, 2016, 205, 351-359
4.520Citations (PDF)
64Distinguishing medication‐free subjects with unipolar disorder from subjects with bipolar disorder: state matters
Bipolar Disorders, 2016, 18, 612-623
2.163Citations (PDF)
65Is frequent attendance of longer duration related to less transient episodes of care? A retrospective analysis of transient and chronic episodes of care
BMJ Open, 2016, 6, e012563
1.94Citations (PDF)
66The effects of interventions on quality of life, morbidity and consultation frequency in frequent attenders in primary care: A systematic review1.729Citations (PDF)
67Perceived ethnic discrimination and depressive symptoms: the buffering effects of ethnic identity, religion and ethnic social network2.662Citations (PDF)
68Meta-analysis and meta-regression of omega-3 polyunsaturated fatty acid supplementation for major depressive disorder
Translational Psychiatry, 2016, 6, e756-e756
5.2263Citations (PDF)
69Enlarged striatal volume in adults with ADHD carrying the 9-6 haplotype of the dopamine transporter gene DAT1
Journal of Neural Transmission, 2016, 123, 905-915
3.425Citations (PDF)
70Prevalence of depressive symptoms among patients with a chronic nonspecific lung disease in five ethnic minority groups
General Hospital Psychiatry, 2015, 37, 513-517
2.63Citations (PDF)
71Patients' perspective on self‐management in the recovery from depression
Health Expectations, 2015, 18, 1339-1348
2.964Citations (PDF)
72Clinician Experiences Assessing Work Disability Related to Mental Disorders
PLoS ONE, 2015, 10, e0119009
2.312Citations (PDF)
73The contribution of perceived ethnic discrimination to the prevalence of depression0.399Citations (PDF)
74Longitudinal effects of the SSRI paroxetine on salivary cortisol in Major Depressive Disorder
Psychoneuroendocrinology, 2015, 52, 261-271
2.763Citations (PDF)
75Do unfavourable working conditions explain mental health inequalities between ethnic groups?: cross-sectional data of the HELIUS study
BMC Public Health, 2015, 15,
3.117Citations (PDF)
76Altered one-carbon metabolism in posttraumatic stress disorder
Journal of Affective Disorders, 2015, 184, 277-285
4.513Citations (PDF)
77Deviant white matter structure in adults with attention-deficit/hyperactivity disorder points to aberrant myelination and affects neuropsychological performance3.885Citations (PDF)
78Enduring effects of Preventive Cognitive Therapy in adults remitted from recurrent depression: A 10 year follow-up of a randomized controlled trial
Journal of Affective Disorders, 2015, 185, 188-194
4.542Citations (PDF)
79Predictors of impaired work functioning in employees with major depression in remission
Journal of Affective Disorders, 2015, 185, 180-187
4.550Citations (PDF)
80DHEAS and cortisol/DHEAS-ratio in recurrent depression: State, or trait predicting 10-year recurrence?
Psychoneuroendocrinology, 2015, 59, 91-101
2.754Citations (PDF)
81Interaction of the 5-HTTLPR and childhood trauma influences memory bias in healthy individuals4.513Citations (PDF)
82Decreased Resting-State Connectivity between Neurocognitive Networks in Treatment Resistant Depression2.474Citations (PDF)
83Erythrocyte fatty acid profiles and plasma homocysteine, folate and vitamin B6 and B12 in recurrent depression: Implications for co-morbidity with cardiovascular disease
Psychiatry Research, 2015, 229, 992-998
3.116Citations (PDF)
84Brain volume in male patients with recent onset schizophrenia with and without cannabis use disorders2.124Citations (PDF)
85Understanding emotion and emotional scarring in recurrent depression
Comprehensive Psychiatry, 2015, 59, 54-61
4.016Citations (PDF)
86Fatty acid metabolism and its longitudinal relationship with the hypothalamic–pituitary–adrenal axis in major depression: Associations with prospective antidepressant response
Psychoneuroendocrinology, 2015, 59, 1-13
2.746Citations (PDF)
87State-Dependent Differences in Emotion Regulation Between Unmedicated Bipolar Disorder and Major Depressive Disorder
JAMA Psychiatry, 2015, 72, 687
12.487Citations (PDF)
88Adding mindfulness-based cognitive therapy to maintenance antidepressant medication for prevention of relapse/recurrence in major depressive disorder: Randomised controlled trial4.540Citations (PDF)
89Resting-state functional connectivity in major depressive disorder: A review6.8908Citations (PDF)
90Childhood abuse and deprivation are associated with distinct sex-dependent differences in brain morphology
Neuropsychopharmacology, 2015, 41, 1716-1723
5.459Citations (PDF)
91Perceived Impeding Factors for Return-to-Work after Long-Term Sickness Absence Due to Major Depressive Disorder: A Concept Mapping Approach
PLoS ONE, 2014, 9, e85038
2.331Citations (PDF)
92Perceived ethnic discrimination and depressive symptoms: the protective effects of ethnic identity, religion, and ethnic social network0.30Citations (PDF)
93Experienced continuity of care in patients at risk for depression in primary care1.710Citations (PDF)
94Why do they keep coming back? Psychosocial etiology of persistence of frequent attendance in primary care: A prospective cohort study2.156Citations (PDF)
95Helpful self-management strategies to cope with enduring depression from the patients’ point of view: a concept map study
BMC Psychiatry, 2014, 14,
3.126Citations (PDF)
96Occupancy of serotonin transporters in the amygdala by paroxetine in association with attenuation of left amygdala activation by negative faces in major depressive disorder1.918Citations (PDF)
97The one-carbon-cycle and methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism in recurrent major depressive disorder; influence of antidepressant use and depressive state?
Journal of Affective Disorders, 2014, 166, 115-123
4.518Citations (PDF)
98Patients׳ perspectives on how treatment can impede their recovery from depression
Journal of Affective Disorders, 2014, 167, 153-159
4.530Citations (PDF)
99Severe Hypertension Related to Caffeinated Coffee and Tranylcypromine: A Case Report
Annals of Internal Medicine, 2014, 160, 657-658
9.67Citations (PDF)
100Cost-effectiveness of adherence therapy versus health education for people with schizophrenia: randomised controlled trial in four European countries1.98Citations (PDF)
101Assessing the burden of caregivers of patients with mental disorders: translating and validating the Involvement Evaluation Questionnaire into Greek2.39Citations (PDF)
102Neural correlates of dysfunctional emotion regulation in major depressive disorder. A systematic review of neuroimaging studies6.8465Citations (PDF)
103Longitudinal relationship between depressive symptoms and work outcomes in clinically treated patients with long-term sickness absence related to major depressive disorder
Journal of Affective Disorders, 2013, 148, 272-277
4.530Citations (PDF)
104Morbidity and doctor characteristics only partly explain the substantial healthcare expenditures of frequent attenders: a record linkage study between patient data and reimbursements data2.842Citations (PDF)
105Addiction treatment in deprived urban areas in EU countries: Accessibility of care for people from socially marginalized groups1.212Citations (PDF)
106Relationship between the hypothalamic–pituitary–adrenal-axis and fatty acid metabolism in recurrent depression
Psychoneuroendocrinology, 2013, 38, 1607-1617
2.768Citations (PDF)
107Mental health-care provision for marginalized groups across Europe: findings from the PROMO study0.346Citations (PDF)
108Adjuvant occupational therapy improves long-term depression recovery and return-to-work in good health in sick-listed employees with major depression: results of a randomised controlled trial2.8102Citations (PDF)
109Interaction between the MTHFR C677T polymorphism and traumatic childhood events predicts depression
Translational Psychiatry, 2013, 3, e288-e288
5.260Citations (PDF)
110Mood reactivity rather than cognitive reactivity is predictive of depressive relapse: A randomized study with 5.5-year follow-up.2.352Citations (PDF)
111Effects of short-term varenicline administration on cortisol in healthy, non-smoking adults: a randomized, double-blind, study
Psychopharmacology, 2013, 231, 143-148
2.82Citations (PDF)
112Predictability of Persistent Frequent Attendance in Primary Care: A Temporal and Geographical Validation Study
PLoS ONE, 2013, 8, e73125
2.37Citations (PDF)
113Ala54Thr Fatty Acid-Binding Protein 2 (FABP2) Polymorphism in Recurrent Depression: Associations with Fatty Acid Concentrations and Waist Circumference
PLoS ONE, 2013, 8, e82980
2.318Citations (PDF)
114The Coping with Attention and Memory Complaints Questionnaire (CAMQ): Psychometric evaluation of an instrument in suspected chronic solvent-induced encephalopathy (CSE)2.10Citations (PDF)
115Lower cortisol levels predict recurrence in remitted patients with recurrent depression: A 5.5 year prospective study
Psychiatry Research, 2012, 200, 281-287
3.154Citations (PDF)
116Cognitive functioning in euthymic recurrently depressed patients: Relationship with future relapses and prior course of disease
Journal of Affective Disorders, 2012, 141, 300-307
4.529Citations (PDF)
117Good practice in mental health care for socially marginalised groups in Europe: a qualitative study of expert views in 14 countries
BMC Public Health, 2012, 12,
3.173Citations (PDF)
118Mental health care for irregular migrants in Europe: Barriers and how they are overcome
BMC Public Health, 2012, 12,
3.152Citations (PDF)
119Service provision and barriers to care for homeless people with mental health problems across 14 European capital cities2.593Citations (PDF)
120Caregiving in severe mental illness: the psychometric properties of the Involvement Evaluation Questionnaire in Portugal2.38Citations (PDF)
121Statistical Methodological Issues in Handling of Fatty Acid Data: Percentage or Concentration, Imputation and Indices
Lipids, 2012, 47, 541-547
1.355Citations (PDF)
122Staging methods for treatment resistant depression. A systematic review4.5201Citations (PDF)
123Return to work after sick leave due to depression; A conceptual analysis based on perspectives of patients, supervisors and occupational physicians
Journal of Affective Disorders, 2012, 136, 1017-1026
4.547Citations (PDF)
124Sustained medically unexplained physical symptoms in euthymic patients with recurrent depression: Predictive value for recurrence and associations with omega 3- and 6 fatty acids and 5-HTTLPR?
Journal of Affective Disorders, 2012, 136, 604-611
4.52Citations (PDF)
125Longitudinal hypothalamic–pituitary–adrenal axis trait and state effects in recurrent depression
Psychoneuroendocrinology, 2012, 37, 892-902
2.792Citations (PDF)
126Impact of psychosis on Portuguese caregivers: a cross-cultural exploration of burden, distress, positive aspects and clinical-functional correlates2.642Citations (PDF)
127Therapygenetics: the 5HTTLPR as a biomarker for response to psychological therapy?
Molecular Psychiatry, 2012, 18, 744-745
7.825Citations (PDF)
128Towards a New Definition of Return-to-Work Outcomes in Common Mental Disorders from a Multi-Stakeholder Perspective
PLoS ONE, 2012, 7, e39947
2.352Citations (PDF)
129Can a One-Item Mood Scale Do the Trick? Predicting Relapse over 5.5-Years in Recurrent Depression
PLoS ONE, 2012, 7, e46796
2.353Citations (PDF)
130Biological Effects of Add-On Eicosapentaenoic Acid Supplementation in Diabetes Mellitus and Co-Morbid Depression: A Randomized Controlled Trial
PLoS ONE, 2012, 7, e49431
2.333Citations (PDF)
131Successful Pharmacologic Treatment of Major Depressive Disorder Attenuates Amygdala Activation to Negative Facial Expressions1.8111Citations (PDF)
132Predictors of Long-Term Return to Work and Symptom Remission in Sick-Listed Patients With Major Depression
Journal of Clinical Psychiatry, 2012, 73, e1048-e1055
1.851Citations (PDF)
133Illness self-management assessment in psychiatric vocational rehabilitation.0.99Citations (PDF)
134Prevalence of psychiatric disorders in patients with chronic solvent induced encephalopathy (CSE)
NeuroToxicology, 2011, 32, 916-922
3.718Citations (PDF)
135Measurement invariance with respect to ethnicity of the Patient Health Questionnaire-9 (PHQ-9)
Journal of Affective Disorders, 2011, 129, 229-235
4.581Citations (PDF)
136The psychometric properties of the panic disorder module of the Patient Health Questionnaire (PHQ-PD) in high-risk groups in primary care
Journal of Affective Disorders, 2011, 130, 260-267
4.535Citations (PDF)
137The predictive validity of subjective adherence measures in patients with schizophrenia2.219Citations (PDF)
138Social ties and short‐term self‐reported delinquent behaviour of personality disordered forensic outpatients1.418Citations (PDF)
139Depression and anxiety: Associations with biological and perceived stress reactivity to a psychological stress protocol in a middle-aged population
Psychoneuroendocrinology, 2010, 35, 866-877
2.7142Citations (PDF)
140Development of an intervention program to increase effective behaviours by patients and clinicians in psychiatric services: Intervention Mapping study2.523Citations (PDF)
141Health related quality of life in recurrent depression: A comparison with a general population sample
Journal of Affective Disorders, 2010, 120, 126-132
4.581Citations (PDF)
142Ambivalent connections: a qualitative study of the care experiences of non-psychotic chronic patients who are perceived as 'difficult' by professionals
BMC Psychiatry, 2010, 10,
3.121Citations (PDF)
143Changes in quality of life in forensic psychiatric outpatients after 6 months of community‐based treatment2.27Citations (PDF)
144Catch 22: A Case of Mutually Denied Chronic Depression
Harvard Review of Psychiatry, 2010, 18, 238-246
1.90Citations (PDF)
145Plasma and Erythrocyte Fatty Acid Patterns in Patients with Recurrent Depression: A Matched Case-Control Study
PLoS ONE, 2010, 5, e10635
2.3123Citations (PDF)
146Prediction of Recurrence in Recurrent Depression1.894Citations (PDF)
147Predictability of persistent frequent attendance: a historic 3-year cohort study1.238Citations (PDF)
148Subjective Well-Being and Recidivism in Forensic Psychiatric Outpatients1.560Citations (PDF)
149Detecting Somatoform Disorders in Primary Care With the PHQ-15
Annals of Family Medicine, 2009, 7, 232-238
1.8184Citations (PDF)
150The accuracy of Patient Health Questionnaire-9 in detecting depression and measuring depression severity in high-risk groups in primary care
General Hospital Psychiatry, 2009, 31, 451-459
2.6113Citations (PDF)
151Recent life events and subjective well-being of personality disordered forensic outpatients0.99Citations (PDF)
152Adherence to continuation and maintenance antidepressant use in recurrent depression
Journal of Affective Disorders, 2009, 115, 167-170
4.576Citations (PDF)
153An empirical method to identify patterns in the course of psychotic episodes of people with schizophrenia2.23Citations (PDF)
154Langdurig frequent bezoek aan de huisarts moeilijk te voorspellen
Huisarts En Wetenschap, 2009, 52, 166-172
0.00Citations (PDF)
155Screening op depressie in hoogrisicogroepen levert te weinig op
Huisarts En Wetenschap, 2009, 52, 269-274
0.05Citations (PDF)
156Wat denken gescreende patiënten met een depressie over hun diagnose?
Huisarts En Wetenschap, 2009, 52, 274-280
0.04Citations (PDF)
157Dosisverhoging SSRI’s bij depressie is niet zinvol
Huisarts En Wetenschap, 2009, 52, 289-296
0.00Citations (PDF)
158Serotonin transporter binding with [123I]β-CIT SPECT in major depressive disorder versus controls: effect of season and gender5.588Citations (PDF)
159Course of adherence to medication and quality of life in people with schizophrenia
Psychiatry Research, 2009, 165, 224-233
3.127Citations (PDF)
160Caring for people with depression or with schizophrenia: Are the consequences different?
Psychiatry Research, 2009, 169, 62-69
3.155Citations (PDF)
161Serotonin transporter gene promoter polymorphisms modify the association between paroxetine serotonin transporter occupancy and clinical response in major depressive disorder1.246Citations (PDF)
162Quality of life of male outpatients with personality disorders or psychotic disorders: a comparison0.916Citations (PDF)
163Cerebral impairment in chronic solvent‐induced encephalopathy
Annals of Neurology, 2008, 63, 572-580
6.646Citations (PDF)
164Polymorphisms in the brain‐specific thyroid hormone transporter OATP1C1 are associated with fatigue and depression in hypothyroid patients
Clinical Endocrinology, 2008, 69, 804-811
2.388Citations (PDF)
165Clinical problems in the long‐term care of patients with chronic depression
Journal of Advanced Nursing, 2008, 62, 689-697
3.325Citations (PDF)
166SF-36 scales, and simple sums of scales, were reliable quality-of-life summaries for patients with schizophrenia3.737Citations (PDF)
167Interventions on frequent attenders in primary care1.946Citations (PDF)
168Patients' view on screening for depression in general practice
Family Practice, 2008, 25, 438-444
2.337Citations (PDF)
169Quality of life of violent and sexual offenders in community-based forensic psychiatric treatment1.019Citations (PDF)
170Is the Defined Daily Dose system a reliable tool for standardizing antipsychotic dosages?1.282Citations (PDF)
171Assessment of Medication Adherence in Patients With Schizophrenia1.048Citations (PDF)
172Evidence Why Paroxetine Dose Escalation is Not Effective in Major Depressive Disorder: A Randomized Controlled Trial With Assessment of Serotonin Transporter Occupancy
Neuropsychopharmacology, 2008, 34, 999-1010
5.476Citations (PDF)
173Predictors of general quality of life and the mediating role of health related quality of life in patients with schizophrenia2.632Citations (PDF)
174The endorsement of dysfunctional attitudes is associated with an impaired retrieval of specific autobiographical memories in response to matching cues
Memory, 2007, 15, 324-338
1.846Citations (PDF)
175Nonresponse to Treatment for Depression Following Myocardial Infarction: Association With Subsequent Cardiac Events
American Journal of Psychiatry, 2007, 164, 1371-1378
8.8127Citations (PDF)
176Treatment of Post-Myocardial Infarction Depressive Disorder: A Randomized, Placebo-Controlled Trial With Mirtazapine
Psychosomatic Medicine, 2007, 69, 606-613
2.1152Citations (PDF)
177Predictive value of cognition for different domains of outcome in recent-onset schizophrenia
Psychiatry Research, 2007, 149, 71-80
3.189Citations (PDF)
178Associations of type-D personality and depression with somatic health in myocardial infarction patients2.163Citations (PDF)
179Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: a meta-analysis of monoamine depletion studies
Molecular Psychiatry, 2007, 12, 331-359
7.8749Citations (PDF)
180Magnitude of effect of lithium in short‐term efficacy studies of moderate to severe manic episode
Bipolar Disorders, 2007, 9, 793-798
2.141Citations (PDF)
181Diagnostic accuracy of the mood module of the Patient Health Questionnaire: a systematic review
General Hospital Psychiatry, 2007, 29, 388-395
2.6444Citations (PDF)
182Uit de kliniek: Depressieve stoornissen en arbeid: een complexe relatie0.00Citations (PDF)
183Medication Adherence in Schizophrenia: Exploring Patients', Carers' and Professionals' Views
Schizophrenia Bulletin, 2006, 32, 786-794
3.9128Citations (PDF)
184Glucocorticoids and Relapse of Major Depression (Dexamethasone/Corticotropin-Releasing Hormone Test in Relation to Relapse of Major Depression)
Biological Psychiatry, 2006, 59, 696-701
5.4153Citations (PDF)
185Prediction of depressive disorder following myocardial infarction2.244Citations (PDF)
186Autobiographical memory in the euthymic phase of recurrent depression.
Journal of Abnormal Psychology, 2006, 115, 590-600
1.971Citations (PDF)
187Persistence with polypharmacy and excessive dosing in patients with schizophrenia treated in four European countries1.277Citations (PDF)
188Adherence to Medication and Quality of Life in People With Schizophrenia1.029Citations (PDF)
189Determinants of first- and second-generation antipsychotic drug use in clinically unstable patients with schizophrenia treated in four European countries1.29Citations (PDF)
190Prediction of treatment response by HPA-axis and glucocorticoid receptor polymorphisms in major depression
Psychoneuroendocrinology, 2006, 31, 1154-1163
2.7106Citations (PDF)
191Symptom Dimensions of Depression Following Myocardial Infarction and Their Relationship With Somatic Health Status and Cardiovascular Prognosis
American Journal of Psychiatry, 2006, 163, 138-144
8.8230Citations (PDF)
192Prediction of Recurrence in Recurrent Depression and the Influence of Consecutive Episodes on Vulnerability for Depression1.879Citations (PDF)
193Switching Antidepressants After a First Selective Serotonin Reuptake Inhibitor in Major Depressive Disorder
Journal of Clinical Psychiatry, 2006, 67, 1836-1855
1.8211Citations (PDF)
194Predictors of successful job finding in psychiatric vocational rehabilitation: An expert panel study0.91Citations (PDF)
195Sex Differences in the Subjective Tolerability of Antipsychotic Drugs1.775Citations (PDF)
196Person-related predictors of employment outcomes after participation in psychiatric vocational rehabilitation programmes2.665Citations (PDF)
197Preventing Relapse/Recurrence in Recurrent Depression With Cognitive Therapy: A Randomized Controlled Trial.2.3234Citations (PDF)
198Polymorphisms in Type 2 Deiodinase Are Not Associated with Well-Being, Neurocognitive Functioning, and Preference for Combined Thyroxine/3,5,3′-Triiodothyronine Therapy4.093Citations (PDF)
199Combined Therapy with Levothyroxine and Liothyronine in Two Ratios, Compared with Levothyroxine Monotherapy in Primary Hypothyroidism: a Double-Blind, Randomized, Controlled Clinical Trial4.0175Citations (PDF)
200Predictors of the Early 5-Year Course of Schizophrenia: A Path Analysis
Schizophrenia Bulletin, 2005, 31, 781-791
3.927Citations (PDF)
201Relationship between left ventricular dysfunction and depression following myocardial infarction: data from the MIND-IT
European Heart Journal, 2005, 26, 2650-2656
2.2100Citations (PDF)
202Factor solution of the BPRS-expanded version in schizophrenic outpatients living in five European countries
Schizophrenia Research, 2005, 75, 107-117
2.381Citations (PDF)
203Triiodothyronine Addition to Paroxetine in the Treatment of Major Depressive Disorder4.053Citations (PDF)
204Family caregiving in depression: impact on caregivers' daily life, distress, and help seeking4.5148Citations (PDF)
205Needs for care of patients with schizophrenia and the consequences for their informal caregivers2.622Citations (PDF)
206The personal impact of schizophrenia in Europe
Schizophrenia Research, 2004, 69, 125-132
2.3185Citations (PDF)
207Fatty acids and homocysteine levels in patients with recurrent depression: an explorative pilot study2.756Citations (PDF)
208Elevated salivary dehydroepiandrosterone-sulfate but normal cortisol levels in medicated depressed patients: preliminary findings
Psychiatry Research, 2004, 128, 117-122
3.149Citations (PDF)
209The effectiveness of psychiatric partial hospitalization and day care4.219Citations (PDF)
210The Generic Work Behavior Questionnaire (GWBQ): Assessment of core dimensions of generic work behavior of people with severe mental illnesses in vocational rehabilitation.0.914Citations (PDF)
211Brain volumes as predictor of outcome in recent-onset schizophrenia: a multi-center MRI study
Schizophrenia Research, 2003, 64, 41-52
2.382Citations (PDF)
212Reducing long term sickness absence by an activating intervention in adjustment disorders: a cluster randomised controlled design2.8316Citations (PDF)
213Satisfaction With Mental Health Services Among People With Schizophrenia in Five European Sites: Results From the EPSILON Study
Schizophrenia Bulletin, 2003, 29, 229-245
3.997Citations (PDF)
214People With Schizophrenia in Five Countries: Conceptual Similarities and Intercultural Differences in Family Caregiving
Schizophrenia Bulletin, 2003, 29, 573-586
3.981Citations (PDF)
215Long-Term Memory Deficits in Schizophrenia: Primary or Secondary Dysfunction?
Neuropsychology, 2003, 17, 539-547
1.666Citations (PDF)
216CAREGIVER BURDEN IN RECENT-ONSET SCHIZOPHRENIA AND SPECTRUM DISORDERS: THE INFLUENCE OF SYMPTOMS AND PERSONALITY TRAITS1.066Citations (PDF)
217The course of parental expressed emotion and psychotic episodes after family intervention in recent-onset schizophrenia. A longitudinal study
Schizophrenia Research, 2002, 57, 183-190
2.340Citations (PDF)
218Gender differences in living with schizophrenia. A cross-sectional European multi-site study
Schizophrenia Research, 2002, 57, 191-200
2.341Citations (PDF)
219Treatment of depression after myocardial infarction and the effects on cardiac prognosis and quality of life: Rationale and outline of the Myocardial INfarction and Depression-Intervention Trial (MIND-IT)
American Heart Journal, 2002, 144, 219-225
2.985Citations (PDF)
220Schizophrenic patients without neuropsychological deficits: subgroup, disease severity or cognitive compensation?
Psychiatry Research, 2002, 112, 1-11
3.178Citations (PDF)
221Die EPSILON-Studie: Versorgung von Patienten mit Schizophrenic in fünf europäischen Zentren1.11Citations (PDF)
222Comparing patterns and costs of schizophrenia care in five European countries: the EPSILON study4.1107Citations (PDF)
223Treatment of depression after myocardial infarction and the effects on cardiac prognosis and quality of life: Rationale and outline of the Myocardial INfarction and Depression-Intervention Trial (MIND-IT)
American Heart Journal, 2002, 144, 219-225
2.981Citations (PDF)
224The benefits of interventions for work-related stress2.8712Citations (PDF)
225A comparison of needs of patients with schizophrenia in five European countries: the EPSILON Study
Acta Psychiatrica Scandinavica, 2001, 103, 370-379
4.180Citations (PDF)
226Reliability in multi-site psychiatric studies2.27Citations (PDF)
227Component structure of the Positive And Negative Syndrome Scale (PANSS) in patients with recent-onset schizophrenia and spectrum disorders
Psychopharmacology, 2000, 150, 399-403
2.887Citations (PDF)
228Title is missing!1.171Citations (PDF)
229Family Caregiving in Schizophrenia: Domains and Distress
Schizophrenia Bulletin, 1998, 24, 609-618
3.9214Citations (PDF)
230A survey of an organization for families of patients with serious mental illness in The Netherlands
Psychiatric Services, 1995, 46, 807-813
2.025Citations (PDF)
231Instruments measuring family or caregiver burden in severe mental illness2.6168Citations (PDF)
232The Evaluation of Mental Health Care Transformation in the Cities of Europe2.26Citations (PDF)
233The European Network for Mental Service Evaluation (ENMESH)4.10Citations (PDF)
234Objective and subjective dimensions of family burden2.6175Citations (PDF)
235Effectiveness of a group intervention to reduce sexual transmission risk behavior among MSM living with HIV: a non-randomized controlled pilot study1.42Citations (PDF)
236Charting brain growth and aging at high spatial precision
ELife, 0, 11,
0.7210Citations (PDF)